Applied Pharmaceutical Nanotechnology 2019

October 25, 2019


1 Portland Street

Cambridge, MA 02139 



Plenary Speakers for APN 2019


Greg Troiano, MSE, Vice President of Technology and Chief Engineer, Seer, Inc.

Biomolecular Biosensors for Health Monitoring and Disease Detection - An Update


Ulrich van Andrian, M.D., Ph.D. Mallinckrodt Professor of Immunopathology, Harvard Medical School

Title TBA


Confirmed Speakers for APN 2019


Gilles Besin, PhD, Sr. Director, Immunology, Moderna Therapeutics

Title TBA


Richard Huang, PhD, Senior Director, L.E.A.F. Pharmaceuticals

Title TBA


Clarice Hutchens, PhD, Senior Director, Pfizer

Title TBA


Hakho Lee, Ph.D., Associate Professor, Harvard Medical School 

Title TBA


Christopher Locher, Ph.D., CEO and Founder, Versatope Therapeutics 

Title TBA


Young-Ho Song, Pfizer 

Title TBA


Gokul Swaminathan, PhD, Associate Principal Scientist, Merck Exploratory Science Center, Merck Research Laboratories

Novel Immuno-Modulatory Lipid Nanoparticle Formulations for Vaccines and Immuno-Oncology Applications


Shraddha Thakkar, PhD, Principal Investigator, U.S. FDA

Title TBA


Proposed Sessions for 2019: 

Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology




Please Join our Linkedin Group


Session I: Particle Technology : Early and Late Stage Technology

Session II: Impact of Biology and Immunology in Nanotechnology

Session III: Regulatory Aspects of Nanotechnology


Click here to register for the APN 2019 conference online.

APN 2019 will take place October 25, 2019 at:

Pfizer, Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy